Alzheimer’s disease (AD), involves progressive cognitive impairment primarily associated with cholinergic dysfunction. Dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) continue to represent a validated and clinically relevant therapeutic approach for alleviating cholinergic deficits in...
Y. Khan, Hina Sarfraz, Azmatullah Khan et al.· Journal of Computational Bio...· 0 citations
This review provides a comprehensive overview of recent advances in isatin-based kinase inhibitors, highlighting their design strategies, structure-activity relationships (SAR), and key molecular determinants of potency and selectivity.
A. Mushtaq, Azmatullah Khan, Akasha Maqbool et al.· Future Medicinal Chemistry· 1 citation
Recent advances in multitarget drug development for AD and PD targeting compounds targeting Aβ, BACE1, MAO-B, cholinesterases, metal-ion dyshomeostasis, oxidative stress, and inflammatory pathways are reviewed.
Azmatullah Khan, Abdullah Abdullah, Syeda Farwa Naqvi et al.· Zeitschrift für Naturforschu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.